Kite to Report Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017

Conference Call and Webcast Scheduled for 6:00 AM PT/9:00 AM ET

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that it will report fourth quarter and full year 2016 financial results on Tuesday, February 28, 2017, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 6:00 AM Pacific Time/9:00 AM Eastern Time.

Audio Webcast

The webcast will be made available on the Company's website at www.kitepharma.com under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.

Dial-In Information

Live (U.S. / Canada): 1 (888) 771-4371Live (International): 1 (847) 585-4405Confirmation number: 44040763

About Kite

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170227006283/en/

KiteChristine CassianoSVP, Corporate Communications & Investor Relationsccassiano@kitepharma.comorGreg MannVP, Investor Relationsgmann@kitepharma.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media